OC-16 - Neutrophil extracellular traps and tissue factor-bearing microvesicles: a liaison dangereuse causing overt DIC in cancer patients?
Overt disseminated intravascular coagulation (DIC) is a systemic process characterized by excessive coagulation activation and fibrinolysis that may occur in cancer patients. The underlying pathomechanisms are still poorly understood. Recent experimental studies found an important role for the inter...
Ausführliche Beschreibung
Autor*in: |
Hell, L. [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2016 |
---|
Umfang: |
2 |
---|
Übergeordnetes Werk: |
Enthalten in: DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer - 2012, vascular obstruction, hemorrhage and hemostasis, Amsterdam [u.a.] |
---|---|
Übergeordnetes Werk: |
volume:140 ; year:2016 ; pages:174-175 ; extent:2 |
Links: |
---|
DOI / URN: |
10.1016/S0049-3848(16)30133-5 |
---|
Katalog-ID: |
ELV030172039 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | ELV030172039 | ||
003 | DE-627 | ||
005 | 20230623203928.0 | ||
007 | cr uuu---uuuuu | ||
008 | 180603s2016 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/S0049-3848(16)30133-5 |2 doi | |
028 | 5 | 2 | |a GBVA2016024000005.pica |
035 | |a (DE-627)ELV030172039 | ||
035 | |a (ELSEVIER)S0049-3848(16)30133-5 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | |a 610 | |
082 | 0 | 4 | |a 610 |q DE-600 |
082 | 0 | 4 | |a 610 |q VZ |
082 | 0 | 4 | |a 610 |q VZ |
084 | |a 44.40 |2 bkl | ||
100 | 1 | |a Hell, L. |e verfasserin |4 aut | |
245 | 1 | 0 | |a OC-16 - Neutrophil extracellular traps and tissue factor-bearing microvesicles: a liaison dangereuse causing overt DIC in cancer patients? |
264 | 1 | |c 2016 | |
300 | |a 2 | ||
336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
337 | |a nicht spezifiziert |b z |2 rdamedia | ||
338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
520 | |a Overt disseminated intravascular coagulation (DIC) is a systemic process characterized by excessive coagulation activation and fibrinolysis that may occur in cancer patients. The underlying pathomechanisms are still poorly understood. Recent experimental studies found an important role for the interaction between procoagulant neutrophil extracellular traps (NETs) and tissue factor (TF) in the pathogenesis of thrombosis. | ||
700 | 1 | |a Thaler, J. |4 oth | |
700 | 1 | |a Martinod, K. |4 oth | |
700 | 1 | |a Ay, C. |4 oth | |
700 | 1 | |a Posch, F. |4 oth | |
700 | 1 | |a Wagner, D.D. |4 oth | |
700 | 1 | |a Pabinger, I. |4 oth | |
773 | 0 | 8 | |i Enthalten in |n Elsevier Science |t DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer |d 2012 |d vascular obstruction, hemorrhage and hemostasis |g Amsterdam [u.a.] |w (DE-627)ELV011105356 |
773 | 1 | 8 | |g volume:140 |g year:2016 |g pages:174-175 |g extent:2 |
856 | 4 | 0 | |u https://doi.org/10.1016/S0049-3848(16)30133-5 |3 Volltext |
912 | |a GBV_USEFLAG_U | ||
912 | |a GBV_ELV | ||
912 | |a SYSFLAG_U | ||
912 | |a SSG-OLC-PHA | ||
912 | |a SSG-OPC-PHA | ||
912 | |a GBV_ILN_24 | ||
912 | |a GBV_ILN_40 | ||
936 | b | k | |a 44.40 |j Pharmazie |j Pharmazeutika |q VZ |
951 | |a AR | ||
952 | |d 140 |j 2016 |h 174-175 |g 2 |y 140.2016, S174-, (2 S.) | ||
953 | |2 045F |a 610 |
author_variant |
l h lh |
---|---|
matchkey_str |
helllthalerjmartinodkaycposchfwagnerddpa:2016----:c6etohlxrcluatasntsufcobaigirvsceaiiodneesc |
hierarchy_sort_str |
2016 |
bklnumber |
44.40 |
publishDate |
2016 |
allfields |
10.1016/S0049-3848(16)30133-5 doi GBVA2016024000005.pica (DE-627)ELV030172039 (ELSEVIER)S0049-3848(16)30133-5 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 610 VZ 44.40 bkl Hell, L. verfasserin aut OC-16 - Neutrophil extracellular traps and tissue factor-bearing microvesicles: a liaison dangereuse causing overt DIC in cancer patients? 2016 2 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Overt disseminated intravascular coagulation (DIC) is a systemic process characterized by excessive coagulation activation and fibrinolysis that may occur in cancer patients. The underlying pathomechanisms are still poorly understood. Recent experimental studies found an important role for the interaction between procoagulant neutrophil extracellular traps (NETs) and tissue factor (TF) in the pathogenesis of thrombosis. Thaler, J. oth Martinod, K. oth Ay, C. oth Posch, F. oth Wagner, D.D. oth Pabinger, I. oth Enthalten in Elsevier Science DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer 2012 vascular obstruction, hemorrhage and hemostasis Amsterdam [u.a.] (DE-627)ELV011105356 volume:140 year:2016 pages:174-175 extent:2 https://doi.org/10.1016/S0049-3848(16)30133-5 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-PHA GBV_ILN_24 GBV_ILN_40 44.40 Pharmazie Pharmazeutika VZ AR 140 2016 174-175 2 140.2016, S174-, (2 S.) 045F 610 |
spelling |
10.1016/S0049-3848(16)30133-5 doi GBVA2016024000005.pica (DE-627)ELV030172039 (ELSEVIER)S0049-3848(16)30133-5 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 610 VZ 44.40 bkl Hell, L. verfasserin aut OC-16 - Neutrophil extracellular traps and tissue factor-bearing microvesicles: a liaison dangereuse causing overt DIC in cancer patients? 2016 2 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Overt disseminated intravascular coagulation (DIC) is a systemic process characterized by excessive coagulation activation and fibrinolysis that may occur in cancer patients. The underlying pathomechanisms are still poorly understood. Recent experimental studies found an important role for the interaction between procoagulant neutrophil extracellular traps (NETs) and tissue factor (TF) in the pathogenesis of thrombosis. Thaler, J. oth Martinod, K. oth Ay, C. oth Posch, F. oth Wagner, D.D. oth Pabinger, I. oth Enthalten in Elsevier Science DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer 2012 vascular obstruction, hemorrhage and hemostasis Amsterdam [u.a.] (DE-627)ELV011105356 volume:140 year:2016 pages:174-175 extent:2 https://doi.org/10.1016/S0049-3848(16)30133-5 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-PHA GBV_ILN_24 GBV_ILN_40 44.40 Pharmazie Pharmazeutika VZ AR 140 2016 174-175 2 140.2016, S174-, (2 S.) 045F 610 |
allfields_unstemmed |
10.1016/S0049-3848(16)30133-5 doi GBVA2016024000005.pica (DE-627)ELV030172039 (ELSEVIER)S0049-3848(16)30133-5 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 610 VZ 44.40 bkl Hell, L. verfasserin aut OC-16 - Neutrophil extracellular traps and tissue factor-bearing microvesicles: a liaison dangereuse causing overt DIC in cancer patients? 2016 2 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Overt disseminated intravascular coagulation (DIC) is a systemic process characterized by excessive coagulation activation and fibrinolysis that may occur in cancer patients. The underlying pathomechanisms are still poorly understood. Recent experimental studies found an important role for the interaction between procoagulant neutrophil extracellular traps (NETs) and tissue factor (TF) in the pathogenesis of thrombosis. Thaler, J. oth Martinod, K. oth Ay, C. oth Posch, F. oth Wagner, D.D. oth Pabinger, I. oth Enthalten in Elsevier Science DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer 2012 vascular obstruction, hemorrhage and hemostasis Amsterdam [u.a.] (DE-627)ELV011105356 volume:140 year:2016 pages:174-175 extent:2 https://doi.org/10.1016/S0049-3848(16)30133-5 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-PHA GBV_ILN_24 GBV_ILN_40 44.40 Pharmazie Pharmazeutika VZ AR 140 2016 174-175 2 140.2016, S174-, (2 S.) 045F 610 |
allfieldsGer |
10.1016/S0049-3848(16)30133-5 doi GBVA2016024000005.pica (DE-627)ELV030172039 (ELSEVIER)S0049-3848(16)30133-5 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 610 VZ 44.40 bkl Hell, L. verfasserin aut OC-16 - Neutrophil extracellular traps and tissue factor-bearing microvesicles: a liaison dangereuse causing overt DIC in cancer patients? 2016 2 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Overt disseminated intravascular coagulation (DIC) is a systemic process characterized by excessive coagulation activation and fibrinolysis that may occur in cancer patients. The underlying pathomechanisms are still poorly understood. Recent experimental studies found an important role for the interaction between procoagulant neutrophil extracellular traps (NETs) and tissue factor (TF) in the pathogenesis of thrombosis. Thaler, J. oth Martinod, K. oth Ay, C. oth Posch, F. oth Wagner, D.D. oth Pabinger, I. oth Enthalten in Elsevier Science DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer 2012 vascular obstruction, hemorrhage and hemostasis Amsterdam [u.a.] (DE-627)ELV011105356 volume:140 year:2016 pages:174-175 extent:2 https://doi.org/10.1016/S0049-3848(16)30133-5 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-PHA GBV_ILN_24 GBV_ILN_40 44.40 Pharmazie Pharmazeutika VZ AR 140 2016 174-175 2 140.2016, S174-, (2 S.) 045F 610 |
allfieldsSound |
10.1016/S0049-3848(16)30133-5 doi GBVA2016024000005.pica (DE-627)ELV030172039 (ELSEVIER)S0049-3848(16)30133-5 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 610 VZ 44.40 bkl Hell, L. verfasserin aut OC-16 - Neutrophil extracellular traps and tissue factor-bearing microvesicles: a liaison dangereuse causing overt DIC in cancer patients? 2016 2 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Overt disseminated intravascular coagulation (DIC) is a systemic process characterized by excessive coagulation activation and fibrinolysis that may occur in cancer patients. The underlying pathomechanisms are still poorly understood. Recent experimental studies found an important role for the interaction between procoagulant neutrophil extracellular traps (NETs) and tissue factor (TF) in the pathogenesis of thrombosis. Thaler, J. oth Martinod, K. oth Ay, C. oth Posch, F. oth Wagner, D.D. oth Pabinger, I. oth Enthalten in Elsevier Science DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer 2012 vascular obstruction, hemorrhage and hemostasis Amsterdam [u.a.] (DE-627)ELV011105356 volume:140 year:2016 pages:174-175 extent:2 https://doi.org/10.1016/S0049-3848(16)30133-5 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-PHA GBV_ILN_24 GBV_ILN_40 44.40 Pharmazie Pharmazeutika VZ AR 140 2016 174-175 2 140.2016, S174-, (2 S.) 045F 610 |
language |
English |
source |
Enthalten in DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer Amsterdam [u.a.] volume:140 year:2016 pages:174-175 extent:2 |
sourceStr |
Enthalten in DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer Amsterdam [u.a.] volume:140 year:2016 pages:174-175 extent:2 |
format_phy_str_mv |
Article |
bklname |
Pharmazie Pharmazeutika |
institution |
findex.gbv.de |
dewey-raw |
610 |
isfreeaccess_bool |
false |
container_title |
DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer |
authorswithroles_txt_mv |
Hell, L. @@aut@@ Thaler, J. @@oth@@ Martinod, K. @@oth@@ Ay, C. @@oth@@ Posch, F. @@oth@@ Wagner, D.D. @@oth@@ Pabinger, I. @@oth@@ |
publishDateDaySort_date |
2016-01-01T00:00:00Z |
hierarchy_top_id |
ELV011105356 |
dewey-sort |
3610 |
id |
ELV030172039 |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV030172039</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623203928.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2016 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/S0049-3848(16)30133-5</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2016024000005.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV030172039</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0049-3848(16)30133-5</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.40</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Hell, L.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">OC-16 - Neutrophil extracellular traps and tissue factor-bearing microvesicles: a liaison dangereuse causing overt DIC in cancer patients?</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">2</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Overt disseminated intravascular coagulation (DIC) is a systemic process characterized by excessive coagulation activation and fibrinolysis that may occur in cancer patients. The underlying pathomechanisms are still poorly understood. Recent experimental studies found an important role for the interaction between procoagulant neutrophil extracellular traps (NETs) and tissue factor (TF) in the pathogenesis of thrombosis.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Thaler, J.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Martinod, K.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ay, C.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Posch, F.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wagner, D.D.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Pabinger, I.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="t">DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer</subfield><subfield code="d">2012</subfield><subfield code="d">vascular obstruction, hemorrhage and hemostasis</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV011105356</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:140</subfield><subfield code="g">year:2016</subfield><subfield code="g">pages:174-175</subfield><subfield code="g">extent:2</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/S0049-3848(16)30133-5</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.40</subfield><subfield code="j">Pharmazie</subfield><subfield code="j">Pharmazeutika</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">140</subfield><subfield code="j">2016</subfield><subfield code="h">174-175</subfield><subfield code="g">2</subfield><subfield code="y">140.2016, S174-, (2 S.)</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
author |
Hell, L. |
spellingShingle |
Hell, L. ddc 610 bkl 44.40 OC-16 - Neutrophil extracellular traps and tissue factor-bearing microvesicles: a liaison dangereuse causing overt DIC in cancer patients? |
authorStr |
Hell, L. |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV011105356 |
format |
electronic Article |
dewey-ones |
610 - Medicine & health |
delete_txt_mv |
keep |
author_role |
aut |
collection |
elsevier |
remote_str |
true |
illustrated |
Not Illustrated |
topic_title |
610 610 DE-600 610 VZ 44.40 bkl OC-16 - Neutrophil extracellular traps and tissue factor-bearing microvesicles: a liaison dangereuse causing overt DIC in cancer patients? |
topic |
ddc 610 bkl 44.40 |
topic_unstemmed |
ddc 610 bkl 44.40 |
topic_browse |
ddc 610 bkl 44.40 |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
zu |
author2_variant |
j t jt k m km c a ca f p fp d w dw i p ip |
hierarchy_parent_title |
DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer |
hierarchy_parent_id |
ELV011105356 |
dewey-tens |
610 - Medicine & health |
hierarchy_top_title |
DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer |
isfreeaccess_txt |
false |
familylinks_str_mv |
(DE-627)ELV011105356 |
title |
OC-16 - Neutrophil extracellular traps and tissue factor-bearing microvesicles: a liaison dangereuse causing overt DIC in cancer patients? |
ctrlnum |
(DE-627)ELV030172039 (ELSEVIER)S0049-3848(16)30133-5 |
title_full |
OC-16 - Neutrophil extracellular traps and tissue factor-bearing microvesicles: a liaison dangereuse causing overt DIC in cancer patients? |
author_sort |
Hell, L. |
journal |
DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer |
journalStr |
DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer |
lang_code |
eng |
isOA_bool |
false |
dewey-hundreds |
600 - Technology |
recordtype |
marc |
publishDateSort |
2016 |
contenttype_str_mv |
zzz |
container_start_page |
174 |
author_browse |
Hell, L. |
container_volume |
140 |
physical |
2 |
class |
610 610 DE-600 610 VZ 44.40 bkl |
format_se |
Elektronische Aufsätze |
author-letter |
Hell, L. |
doi_str_mv |
10.1016/S0049-3848(16)30133-5 |
dewey-full |
610 |
title_sort |
oc-16 - neutrophil extracellular traps and tissue factor-bearing microvesicles: a liaison dangereuse causing overt dic in cancer patients? |
title_auth |
OC-16 - Neutrophil extracellular traps and tissue factor-bearing microvesicles: a liaison dangereuse causing overt DIC in cancer patients? |
abstract |
Overt disseminated intravascular coagulation (DIC) is a systemic process characterized by excessive coagulation activation and fibrinolysis that may occur in cancer patients. The underlying pathomechanisms are still poorly understood. Recent experimental studies found an important role for the interaction between procoagulant neutrophil extracellular traps (NETs) and tissue factor (TF) in the pathogenesis of thrombosis. |
abstractGer |
Overt disseminated intravascular coagulation (DIC) is a systemic process characterized by excessive coagulation activation and fibrinolysis that may occur in cancer patients. The underlying pathomechanisms are still poorly understood. Recent experimental studies found an important role for the interaction between procoagulant neutrophil extracellular traps (NETs) and tissue factor (TF) in the pathogenesis of thrombosis. |
abstract_unstemmed |
Overt disseminated intravascular coagulation (DIC) is a systemic process characterized by excessive coagulation activation and fibrinolysis that may occur in cancer patients. The underlying pathomechanisms are still poorly understood. Recent experimental studies found an important role for the interaction between procoagulant neutrophil extracellular traps (NETs) and tissue factor (TF) in the pathogenesis of thrombosis. |
collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-PHA GBV_ILN_24 GBV_ILN_40 |
title_short |
OC-16 - Neutrophil extracellular traps and tissue factor-bearing microvesicles: a liaison dangereuse causing overt DIC in cancer patients? |
url |
https://doi.org/10.1016/S0049-3848(16)30133-5 |
remote_bool |
true |
author2 |
Thaler, J. Martinod, K. Ay, C. Posch, F. Wagner, D.D. Pabinger, I. |
author2Str |
Thaler, J. Martinod, K. Ay, C. Posch, F. Wagner, D.D. Pabinger, I. |
ppnlink |
ELV011105356 |
mediatype_str_mv |
z |
isOA_txt |
false |
hochschulschrift_bool |
false |
author2_role |
oth oth oth oth oth oth |
doi_str |
10.1016/S0049-3848(16)30133-5 |
up_date |
2024-07-06T16:53:02.914Z |
_version_ |
1803849336528830465 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV030172039</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623203928.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2016 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/S0049-3848(16)30133-5</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2016024000005.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV030172039</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0049-3848(16)30133-5</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.40</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Hell, L.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">OC-16 - Neutrophil extracellular traps and tissue factor-bearing microvesicles: a liaison dangereuse causing overt DIC in cancer patients?</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">2</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Overt disseminated intravascular coagulation (DIC) is a systemic process characterized by excessive coagulation activation and fibrinolysis that may occur in cancer patients. The underlying pathomechanisms are still poorly understood. Recent experimental studies found an important role for the interaction between procoagulant neutrophil extracellular traps (NETs) and tissue factor (TF) in the pathogenesis of thrombosis.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Thaler, J.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Martinod, K.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ay, C.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Posch, F.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wagner, D.D.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Pabinger, I.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="t">DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer</subfield><subfield code="d">2012</subfield><subfield code="d">vascular obstruction, hemorrhage and hemostasis</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV011105356</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:140</subfield><subfield code="g">year:2016</subfield><subfield code="g">pages:174-175</subfield><subfield code="g">extent:2</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/S0049-3848(16)30133-5</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.40</subfield><subfield code="j">Pharmazie</subfield><subfield code="j">Pharmazeutika</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">140</subfield><subfield code="j">2016</subfield><subfield code="h">174-175</subfield><subfield code="g">2</subfield><subfield code="y">140.2016, S174-, (2 S.)</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
score |
7.398737 |